Nakata Keiichi, Ueda Shuji, Matsunaga Hitomi, Mima Fuka, Ueda Hiroki, Yoshioka Aya, Kaneko Sayoko, Maruo Kazushi, Morris Shayne, Yonemoto Sayoko, Hayashi Daisuke, Fujii Naohiko, Narahara Hiroyuki, Inui Yoshiaki, Kawata Sumio
Department of Internal Medicine, Hyogo Prefectural Nishinomiya Hospital, Japan.
Department of Clinical Laboratory, Hyogo Prefectural Nishinomiya Hospital, Japan.
Intern Med. 2018 Feb 1;57(3):393-397. doi: 10.2169/internalmedicine.9150-17. Epub 2017 Nov 1.
Acquired coagulation factor inhibitor is a rare coagulation disorder. We herein report a patient with acquired factor V inhibitor showing a decrease in multiple coagulation factor activities. A high titer of factor V inhibitor presumably led to a marked inhibition of factor V activity in the specific factor-deficient plasma used in coagulation factor activity assays based on either an activated partial thromboplastin time (APTT) or prothrombin time (PT) clotting assay, resulting in false low values of the coagulation activity. We re-examined the coagulation factor activity using several dilutions of the patient's plasma and confirmed that the high factor V inhibitor titer had caused an apparent decrease in multiple coagulation factor activities.
获得性凝血因子抑制剂是一种罕见的凝血障碍。我们在此报告一例患有获得性因子V抑制剂的患者,其多种凝血因子活性降低。高滴度的因子V抑制剂可能导致在基于活化部分凝血活酶时间(APTT)或凝血酶原时间(PT)凝血试验的凝血因子活性测定中,所用特定因子缺乏血浆中因子V活性受到显著抑制,从而导致凝血活性出现假低值。我们使用患者血浆的几种稀释度重新检测了凝血因子活性,并证实高因子V抑制剂滴度导致多种凝血因子活性明显降低。